| Pemphigus group: overview, epidemiology, mortality, and comorbidities K Kridin Immunologic research 66 (2), 255-270, 2018 | 258 | 2018 |
| The growing incidence of bullous pemphigoid: overview and potential explanations K Kridin, RJ Ludwig Frontiers in medicine 5, 220, 2018 | 214 | 2018 |
| Association of bullous pemphigoid with dipeptidyl-peptidase 4 inhibitors in patients with diabetes: estimating the risk of the new agents and characterizing the patients K Kridin, R Bergman JAMA dermatology 154 (10), 1152-1158, 2018 | 169 | 2018 |
| COVID‐19 related masks increase severity of both acne (maskne) and rosacea (mask rosacea): multi‐center, real‐life, telemedical, and observational prospective study G Damiani, LC Gironi, A Grada, K Kridin, R Finelli, A Buja, NL Bragazzi, ... Dermatologic Therapy 34 (2), e14848, 2021 | 118 | 2021 |
| The role of eosinophils in bullous pemphigoid: a developing model of eosinophil pathogenicity in mucocutaneous disease KT Amber, M Valdebran, K Kridin, SA Grando Frontiers in Medicine 5, 201, 2018 | 118 | 2018 |
| Mortality and cause of death in patients with pemphigus. K Kridin, S Zelber-Sagi, R Bergman Acta dermato-venereologica 97 (5), 2017 | 106 | 2017 |
| COVID-19 prevalence and mortality among schizophrenia patients: a large-scale retrospective cohort study D Tzur Bitan, I Krieger, K Kridin, D Komantscher, Y Scheinman, ... Schizophrenia Bulletin 47 (5), 1211-1217, 2021 | 105 | 2021 |
| Updated S2 K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (EADV) L Borradori, N Van Beek, C Feliciani, B Tedbirt, E Antiga, R Bergman, ... Journal of the European Academy of Dermatology and Venereology 36 (10), 1689 …, 2022 | 95 | 2022 |
| Subepidermal autoimmune bullous diseases: overview, epidemiology, and associations K Kridin Immunologic research 66 (1), 6-17, 2018 | 95 | 2018 |
| Underlying systemic diseases in pyoderma gangrenosum: a systematic review and meta-analysis K Kridin, AD Cohen, KT Amber American journal of clinical dermatology 19, 479-487, 2018 | 93 | 2018 |
| Pemphigus vulgaris and pemphigus foliaceus: differences in epidemiology and mortality K Kridin, S Zelber-Sagi, R Bergman Acta dermato-venereologica 97 (9), 1095-1099, 2017 | 90 | 2017 |
| Emerging treatment options for the management of pemphigus vulgaris K Kridin Therapeutics and clinical risk management, 757-778, 2018 | 88 | 2018 |
| Epidemiology of pemphigus K Kridin, E Schmidt JID innovations 1 (1), 100004, 2021 | 87 | 2021 |
| Serum and blister fluid levels of cytokines and chemokines in pemphigus and bullous pemphigoid EH Kowalski, D Kneibner, K Kridin, KT Amber Autoimmunity reviews 18 (5), 526-534, 2019 | 86 | 2019 |
| Lichen planus K Boch, EA Langan, K Kridin, D Zillikens, RJ Ludwig, K Bieber Frontiers in medicine 8, 737813, 2021 | 82 | 2021 |
| Epidermolysis bullosa acquisita: A comprehensive review K Kridin, D Kneiber, EH Kowalski, M Valdebran, KT Amber Autoimmunity Reviews 18 (8), 786-795, 2019 | 77 | 2019 |
| Unmet medical needs in chronic, non-communicable inflammatory skin diseases H Ujiie, D Rosmarin, MP Schön, S Ständer, K Boch, M Metz, M Maurer, ... Frontiers in medicine 9, 875492, 2022 | 74 | 2022 |
| Mortality in patients with bullous pemphigoid: a retrospective cohort study, systematic review and meta-analysis. K Kridin, W Shihade, R Bergman Acta Dermato-Venereologica 99 (1), 2019 | 73 | 2019 |
| Peripheral eosinophilia in bullous pemphigoid: prevalence and influence on the clinical manifestation K Kridin British Journal of Dermatology 179 (5), 1141-1147, 2018 | 73 | 2018 |
| Post-rituximab immunoglobulin M (IgM) hypogammaglobulinemia K Kridin, AR Ahmed Autoimmunity reviews 19 (3), 102466, 2020 | 70 | 2020 |
